Evaluating sparsentan for the treatment of focal segmental glomerulosclerosis
ABSTRACT Introduction Focal segmental glomerulosclerosis (FSGS) represents a histopathologic pattern of glomerular injury rather than a single disease entity. In FSGS, prognosis varies substantially according to the degree of proteinuria. Despite optimized supportive therapy and, in presumed primary FSGS, immunosuppres...